glp-1 and alzheimer's disease glp1 #diabetes #sglt2 #dementia #alzheimer | Robert Gabbay MD, PhD Neuroprotective Actions of Glucagon-Like Peptide-1

In the SURMOUNT-4 trial, tirzepatide achieved weight reductions of up to 22.5% at the highest dose, with some subgroups showing even greater loss compared to semaglutide alone

Both individual and class action cases are being filed in multiple states, alleging that Novo Nordisk, the manufacturer of Ozempic, failed to adequately warn patients and healthcare providers about the potential risk of serious vision complications

Over time, consistent exercise can help "train" your body to maintain higher baseline levels of antioxidants

At Golden Health and Beauty Center, collagen focused treatments are selected with long term skin health in mind

Nevertheless, in vivo delivery of nucleic acids other than pDNA or mRNA, such as siRNAs or ASOs, to kidney and vascular endothelial cells with actively targeted lipid nanocarriers has been investigated, and these strategies could be applied to pDNA and mRNA delivery

Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 20062013